Ranibizumab Treatment of Diabetic Macular Oedema With Bimonthly Monitoring After a Phase of Initial Treatment
Clinical trial NCT01257815 · COMPLETED
Trial details
- NCT number
- NCT01257815
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2011-01-01
- Primary completion
- 2013-04-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.